News for Memphasys Limited (MEM.AX)

Published at

Jun 17, 2025 6:40 AM

by themarketherald.com.au

positive

positive

Many are concerned about global falling birthrates. This diverse stock has solutions

Outside of US politics, there is one issue that’s been popping up more and more across social media and other forums of commentary in 2025...

MEM.AX

Read more →
Published at

May 8, 2025 4:50 AM

by smallcaps.com.au

positive

positive

Memphasys pilot study confirms RoXsta’s potential as high-throughput antioxidant diagnostic tool

A pilot study has shown that Memphasys’ (ASX: MEM) RoXsta Mega Cell high-throughput assay device can conduct large-scale, simultaneous antioxidant assays

MEM.AX

Read more →
Published at

Mar 24, 2025 4:49 AM

by smallcaps.com.au

mixed

mixed

Memphasys achieves key milestone with clinical validation of Felix fertility device

Memphasys (ASX: MEM) has published positive data from a pivotal clinical trial of its Felix electrophoresis-based sperm separation device for use in

MEM.AX MVF.AX

Read more →
Published at

Mar 24, 2025 3:13 AM

by themarketherald.com.au

mixed

mixed

Monday’s HotCopper Trends: Opthea strife, Errawarra jumps on acquisitions, Memphasys best-in-class trial results | March 21, 2025

The ASX has been trading flat at around 7,928 points. Discretionary has…

MEM.AX ERW.AX OPT.AX

Read more →
Published at

Mar 24, 2025 12:07 AM

by themarketherald.com.au

mixed

mixed

Memphasys tech: Trial results prove it lifts the guys’ game in IVF

Memphasys reproductive technology is proving a gamechanger in the guys' side of infertility – which is behind half of all conception issues.

MEM.AX MVF.AX

Read more →
Published at

Jan 16, 2025 12:28 AM

by themarketherald.com.au

positive

positive

Publication highlights strengths of Memphasys’ antioxidant profiling system

Memphasys Ltd has seen a positive focus on its RoXsta antioxidant profiling system, through the publication of a manuscript on its qualities

MEM.AX

Read more →
Published at

Dec 5, 2024 3:42 AM

by themarketherald.com.au

positive

positive

Sperm tech player Memphasys ships unit to Dubai – but can the stock attract liquidity?

Memphasys (ASX:MEM) has confirmed it's sent a demo unit of its Felix sperm separator system to a hospital in Dubai.

MEM.AX

Read more →
Published at

Mar 17, 2024 11:42 PM

by themarketherald.com.au

mixed

mixed

Market Open: Trepidation as interest rates decision looms

With the RBA interest rates decision due tomorrow, the ASX is expected to open just a little higher this morning.

MEM.AX MIN.AX

Read more →
Published at

Nov 1, 2023 6:36 AM

by investing.com

mixed

mixed

ASX morning trade reveals winners, losers; Novonix expands production with $100 million grant By Investing.com

ASX morning trade reveals winners, losers; Novonix expands production with $100 million grant

TASEF TAS.AX PAR.AX NVX.AX NVNXF BRU.AX MEM.AX ADS.AX

Read more →
Published at

Sep 15, 2023 7:19 AM

by themarketherald.com.au

mixed

mixed

TMH Market Update: Woodside (ASX:WDS) stalls seismic testing at Scarborough gas project off WA

ASX200 is making a strong run into the weekend – up 1.5 per cent with all sectors ahead.

MGU.AX EGL.AX ASN.AX MEM.AX NVX.AX

Read more →
Published at

Sep 15, 2023 6:50 AM

by themarketherald.com.au

positive

positive

Memphasys’ (ASX:MEM) FELIX system records 10 new healthy births in India

Memphasys (ASX:MEM) has announced that its patented sperm isolation technology has resulted in 10 new births in India for couples experiencing difficulties conceiving a child.

MEM.AX

Read more →
Published at

Aug 7, 2023 8:00 PM

by nakedcapitalism.com

neutral

neutral

2:00PM Water Cooler 8/7/2023

Today's Water Cooler

MEM.AX

Read more →
Published at

Apr 30, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

PSQ.AX PGC.AX OSX.AX OPT.AX OPT NOXOF NOX.AX IUGNF IMU.AX GSS.AX CYP.AX CKDXF BPH.AX ATX.AX 4DX.AX ZNO.AX SCU.AX RSH.AX PXSLY PXS.AX PAB.AX OCC.AX NC6.AX KZA.AX KMLXF IHL.AX IDT.AX FDMDF DVL.AX CMP.AX BITRF BIT.AX ARUXF AMT.AX ACR.AX 1AD.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX RNO.AX RHY.AX RHT.AX RGS.AX RAC.AX PYC.AX PNV.AX PCK.AX PBP.AX OVN.AX OSL.AX ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDR.AX MDC.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX ICR.AX HCT.AX GTG.AX GLH.AX EYE.AX DXB.AX CSL.AX CPH.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX AT1.AX ARX.AX AMDHF ALC.AX ADR.AX ADO.AX 1ST.AX

Read more →
Published at

Apr 3, 2023 5:12 AM

by stockhead.com.au

mixed

mixed

ASX Health Stocks: PYC to take second asset to clinical trial; FDA sees no issues in Botanix submission

RNA therapies specialist PYC Therapeutic (ASX:PYC) says it will now progress a second drug development program to human trial.

PYC.AX MEM.AX BOT.AX

Read more →
Published at

Apr 3, 2023 1:56 AM

by themarketherald.com.au

neutral

neutral

Memphasys (ASX:MEM) welcomes first baby born in India using Felix system

Reproductive biotechnology company Memphasys (ASX:MEM) has completed the first commercial sale of its Felix system to a clinic in Japan.

MEM.AX

Read more →
Published at

Apr 3, 2023 1:45 AM

by stockhead.com.au

mixed

mixed

Market Highlights: ASX to rise again, oil prices spike 7pc, and 5 small caps to watch on Monday

Wall Street was once again on buying mode on the last day of the month and quarter. Across the Atlantic, Eurozone inflation hits a record high.

ICE.AX AVA.AX TMT.AX MLS.AX MEM.AX

Read more →
Published at

Apr 2, 2023 7:50 PM

by stockhead.com.au

mixed

mixed

Dr Boreham's Crucible: Every sperm is sacred

When we last covered Memphasys in December 2019: Coutts said she was feeling the investor love after a few barren years.

MX1.AX MVF.AX MEM.AX HYD.AX

Read more →
Published at

Mar 5, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger

Colossal Biosciences’ plans to bring the Tasmanian tiger and woolly mammoth back to life, but now it’s also betting on the iconic dodo.

TD1.AX RGS.AX RAC.AX FFC.AX EZL.AX PYC.AX PAB.AX OPT.AX OPT MX1.AX CMP.AX CKDXF AMT.AX VTG.AX VLS.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX PXSLY PXS.AX PSQ.AX PNV.AX PGC.AX PBP.AX ONE.AX OCC.AX NYR.AX NC6.AX MVF.AX MEM.AX MEB.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMM.AX HCT.AX GTG.AX GSS.AX EYE.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX ATX.AX ARUXF AMDHF ADR.AX ACR.AX

Read more →
Published at

Feb 23, 2023 5:10 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

Why the uranium boom will be a boomer, Guy's feeling all Patriotic, and the FDA countdown for Neuren begins.

XF1.AX TLGRF TLG.AX TD1.AX SLX.AX S2R.AX RED.AX PVS.AX MDC.AX MCT.AX LCL.AX ICG.AX EML.AX DTR.AX DLT.AX DC2.AX CYL.AX CNJ.AX BPP.AX SHJ.AX ROG.AX NWM.AX KNM.AX KNEOF GBR.AX FYI.AX FAU.AX CAV.AX ATU.AX AMD.AX SIO.AX MEM.AX MCM.AX GLV.AX AJQ.AX

Read more →
Published at

Feb 23, 2023 7:09 AM

by stockhead.com.au

mixed

mixed

CLOSING BELL: Is a $1.2 billion dollar catastrophe enough to finally hammer a stake through the heart of Star?

The ASX limped to a 0.4% drop today, while Mt Monger (ASX:MTM) shone bright in precisely the way Star Entertainment Group didn't.

XF1.AX TTT.AX TD1.AX SLX.AX S2R.AX PVS.AX NOR.AX MQGPE.AX MQGPD.AX MQGPC.AX MQG.AX MPL.AX MDC.AX MCT.AX LCL.AX KNM.AX KNEOF ICG.AX EML.AX DTR.AX DC2.AX CYL.AX CNJ.AX CCG.AX BPP.AX AWC.AX AA TLGRF TLG.AX SVL.AX ROG.AX RED.AX NWM.AX NTO.AX GBR.AX FYI.AX FAU.AX DLT.AX CAV.AX ATU.AX AMD.AX SIO.AX SHJ.AX RKN.AX MEM.AX MCM.AX GLV.AX AJQ.AX

Read more →